SIR -It is widely agreed that genetic association mapping is a powerful tool to detect susceptibility genes for complex disorders, even when each of these genes has a small contribution to risk.
1 Given the growing use of association studies in psychiatry, we believe it is imperative to develop and agree upon standards for the way a genetic association study is designed and reported. Here, we propose some standards of general study design, diagnostic assessment, genotyping, and statistical analysis, which we believe will enhance the comparability of future genetic association studies.
Genetic association studies are of growing importance in complex diseases, both as a means of following up genetic linkage signals and of testing candidate gene hypotheses. Association studies have become particularly popular with the advent of dense marker maps, high-throughput genotyping methods, and a host of new statistical methods. This growing popularity has brought with it a growing lack of consistency in study designs and methods, with the inevitable result that 'the vast majority of association studies are not replicable'. used an initial sample of parent-offspring triads, with two independent replication samples. They reported an apparently positive association in the first sample that could not be confirmed in either of the replication samples. The subsequent study by Neves-Pereira et al, 4 which analyzed a sample of 284 probands and their parents, also reported a significant association with the same allele of the same SNP.
Can this be considered a replicated association between BDNF and BPAD? While we sincerely hope so, substantial differences in the design of the two studies (see Table 1 ) raise questions about whether we can properly speak of replication. On the other hand, problems in the design and reporting of both studies (see Table 1 ) make it difficult to dismiss the possibility of another false-positive association finding in a field that already has too many. This is a missed opportunity to provide the field with the much-needed credibility of an unambiguous replication finding.
Perhaps we could agree to adhere to a set of basic standards for future association studies? If followed, such standards could decrease spurious findings, enable the design of targeted replication studies, and make it easier to identify replications when they occur. Previous attempts to set new standards for association studies have ranged from setting the statistical bar so high that only the strongest (but not necessarily most replicable) findings will pass, 5 to throwing out the baby of replication-testing with the bathwater of false-positive results. 6 Still the problems persist.
We suggest a focus on the fundamentals: general study design, genotyping methods, and statistical analysis.
Study design encompasses the choice between case-control and family samples, the ascertainment strategy, considerations about sample size, and the selection of markers. The choice between casecontrol and family samples is influenced by the disorder under study (i.e. availability of parental data in early vs young age at onset (AAO) cases), the recruitment resources, as well as considerations regarding statistical power and robustness (e.g. population stratification).
Ascertainment of samples is a critical factor in the comparability across studies. For instance, familybased samples, featuring predominantly young AAO cases, might differ in underlying genetic susceptibility from case-control samples, which typically contain a higher percentage of sporadic, late AAO cases. 7, 8 Other important differences can result from subtle differences in ascertainment. Parent-offspring trios drawn from multiply affected linkage pedigrees might be genetically different from independently recruited trio-samples. Differences might exist between population-based case-control samples and those recruited from a distinct hospital population. And so on. Thus, we believe that similarity in ascertainment is a key requirement for replication efforts.
Our field should agree that all published studies must give a detailed account of all aspects of study design. The main emphasis should lie on ascertainment criteria, subject recruitment, clinical assessment, and diagnostic methods. Since robustness of findings across studies is highly correlated with sample size, 9 studies should be based on the largest possible samples. Since the patterns of linkage disequilibrium are not monotonic across a gene or population, multiple markers should be genotyped to improve reproducibility. [10] [11] [12] Genotyping: Genotyping methods generate the key genetic data in association studies. The methods used must be nucleotide-specific and highly accurate. Genotype scoring should either be fully automated or carried out in a carefully blinded manner. Positive and negative controls, duplicate controls, and testing for Hardy-Weinberg equilibrium or Mendelian errors should be a feature of every experiment and should be reported along with the published results.
Statistical analysis: Human genetics is currently witnessing the birth of numerous statistical procedures for genetic association mapping. 13 The underlying statistics of these methods are more complex and less transparent than simple tests on contingency tables. Future studies should carefully consider the available methods, choose the minimum number of appropriate tests, and apply them in a manner that is consistent with the underlying assumptions. Power analyses should be performed and reported (not only for negative studies), and correction for multiple testing should be universal. Studies that rely primarily on a TDT-type analysis should always test for transmission distortion.
14 Since genotyping errors can increase the type I error rate in a TDT design, methods that correct for such sources of error warrant consideration. 15 In case-control designs, strategies that detect and control for population stratification 16, 17 should be preferred. Association studies in regions of genetic linkage signals should assess how well putative association findings partition the evidence of linkage in the original sample. 18, 19 Finally, one-tailed P-values should be reserved for replication testing of only the strongest prior hypotheses. 20 We believe the widespread adoption of these proposed standards will lead to an improvement in the quality of association studies. Quality improvement will also help restore the damaged credibility of our field. Credibility would also be improved if raw data were made freely available to other scientists upon publication. As quality improves and the data are shared, true-positive findings will shine through, and unambiguous replicationsFthe one sure path to credibilityFwill follow.
These standards will be discussed at an Invited Session to be presented at the American Society of Human Genetics Annual Meeting in November, 2003. 
